Protein inhibitor of activated STAT3 expression in lung cancer
Authors:
Open Access
- 30 March 2011
- journal article
- research article
- Published by Wiley in Molecular Oncology
- Vol. 5 (3) , 256-264
Abstract
In this study we investigate PIAS3 expression in both non‐small cell lung cancer (NSCLC) cell lines and human resected NSCLC specimens. Expression of PIAS3 is variable in lung cancer cells lines wit...Keywords
This publication has 20 references indexed in Scilit:
- The Association and Nuclear Translocation of the PIAS3-STAT3 Complex Is Ligand and Time DependentMolecular Cancer Research, 2009
- EML4-ALK: Honing In on a New Target in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription‐3 with epidermal growth factor receptor blockade in lung cancerInternational Journal of Cancer, 2009
- Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene ExpressionClinical Cancer Research, 2008
- Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human CancerJournal of Clinical Oncology, 2008
- Activation state egfr and STAT-3 as prognostic markers in resected non-small cell lung cancerLung Cancer, 2007
- Overexpression of PIAS3 Suppresses Cell Growth, Restores the Drug Sensitivity of Human Lung Cancer Cells in Association with PI3-K/Akt InactivationNeoplasia, 2006
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- STATs: transcriptional control and biological impactNature Reviews Molecular Cell Biology, 2002
- A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinasesNature, 1991